Job Description

Dr Li’s laboratory is in the Hugo W. Moser Research Institute at Kennedy Krieger, Inc’s Neuro-Oncology laboratory, which consists of ~2,000 sq feet for molecular biology/biochemistry research and additional shared laboratories for animal manipulations (300 sq ft) and tissue culture (150 sq ft)(https://www.hopkinsmedicine.org/profiles/details/yunqing-li). There is also a core tissue culture laboratory (150 sq ft) designed exclusively for the preparation and use of viral expression vectors. The Neuro-Oncology Laboratories provide a dynamic, highly collaborative, high products, and educational environment. Research will focus on uncovering the immunosuppressive mechanisms of brain tumor growth and immunotherapy resistance. The goal is to develop novel anti-tumor therapeutic strategies to treat brain tumor malignancy.

We are now seeking a highly motivated postdoctoral fellow to join a collaborative team. Preference will be given to candidates with Ph.D and/or M.D. degrees who are early in their post-doctoral training (0-3 yrs) with publication records documenting expertise in cancer immune biology, molecule biology, stem cell biology, and signal transduction.

Application Process:
Please send a cover letter, curriculum vitae, and the names/contact information of three references to [email protected]

Related papers:
Yunqing Li* et al., Editorial: GBM stem cells and the brain tumor microenvironment. Front. Oncol., Sec. NeuroOncology and Neurosurgical Oncology. 2023 Feb 24:13:1153803. PMID: 36923429
Hu et al., ATRX loss promotes immunosuppressive mechanisms in IDH1 mutant glioma. Neuro Oncol. 2022, 24(6):888-900. PMID: 34951647
Ma et al., Reprogramming Transcription Factors Oct4 and Sox2 Induce a BRD-Dependent Immunosuppressive Transcriptome in GBM-Propagating Cells. Cancer Res. 2021 May 81(9): 2457-2469. PMID: 33574085